VS TR 2x Long VIX Futures ETF

ProShares Ultra VIX Short-Term Futures

ProShares Ultra Bloomberg Natural Gas

United States Oil Fund

Direxion Daily S&P Biotech Bear 3X ETF

ProShares Ultra Silver

ProShares Trust ProShares Short Bitcoin Strategy ETF

Direxion Daily 20+ Yr Trsy Bull 3X ETF

United States Natural Gas

Direxion Daily Small Cap Bear 3X ETF

Guggenheim Solar ETF

ProShares UltraShort Bloomberg Natrl Gas

VS TR -1x Short VIX Futures ETF

Direxion Daily S&P Biotech Bull 3X ETF

ProShares UltraShort Silver

ProShares Bitcoin Strategy ETF

Direxion Daily 20+ Yr Trsy Bear 3X ETF

Direxion Daily Small Cap Bull 3X ETF

ProShares UltraPro S&P500

Direxion Daily S&P500 Bull 3X ETF

Reddit Inc. Class A Common Stock

Bath & Body Works Inc.

Cleveland-Cliffs Inc. Common Stock

Helmerich & Payne Inc. Common Stock

First Majestic Silver Corp. Ordinary Shares (Canada)

Endeavour Silver Corporation Ordinary Shares (Canada)

Civitas Resources Inc. Common Stock

CACI International Inc. Class A Common Stock

Valero Energy Corporation Common Stock

JELD-WEN Holding Inc. Common Stock

AgEagle Aerial Systems Inc. Common Stock

Arista Networks Inc. Common Stock

JinkoSolar Holding Company Limited American Depositary Shares (each representing 4 Common Shares)

Delta Air Lines Inc. Common Stock

Lennar Corporation Class A Common Stock

QuantumScape Corporation Class A Common Stock

Genworth Financial Inc Common Stock

Mohawk Industries Inc. Common Stock

Archer Aviation Inc. Class A Common Stock

Oklo Inc.

Click here to get full coverage on GIPR agonism and antagonism decrease body weight and food intake via different mechanisms in male mice - Nature

GIPR agonism and antagonism decrease body weight and food intake via different mechanisms in male mice  Nature

GIPR agonism and antagonism decrease body weight and food intake via different mechanisms in male mice - Nature

Click here to get full coverage on The role of GIPR in food intake control - Frontiers

The role of GIPR in food intake control  Frontiers

The role of GIPR in food intake control - Frontiers

Click here to get full coverage on The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice - ScienceDirect.com

The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice  ScienceDirect.com

The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice - ScienceDirect.com

Click here to get full coverage on Novel GIPR Antagonists for Treating Obesity and Type 2 Diabetes Mellitus - ACS Publications

Novel GIPR Antagonists for Treating Obesity and Type 2 Diabetes Mellitus  ACS Publications

Novel GIPR Antagonists for Treating Obesity and Type 2 Diabetes Mellitus - ACS Publications

Click here to get full coverage on Stimulating fat cells with GIP receptor has potential to treat obesity: Newsroom - UT Southwestern Medical Center

Stimulating fat cells with GIP receptor has potential to treat obesity: Newsroom  UT Southwestern Medical Center

Stimulating fat cells with GIP receptor has potential to treat obesity: Newsroom - UT Southwestern Medical Center

Click here to get full coverage on Antag commences trial of GIPR antagonist for treating obesity - Clinical Trials Arena

Antag commences trial of GIPR antagonist for treating obesity  Clinical Trials Arena

Antag commences trial of GIPR antagonist for treating obesity - Clinical Trials Arena

Click here to get full coverage on GIPR-Ab/GLP-1 peptide–antibody conjugate requires brain GIPR and GLP-1R for additive weight loss in obese mice - Nature

GIPR-Ab/GLP-1 peptide–antibody conjugate requires brain GIPR and GLP-1R for additive weight loss in obese mice  Nature

GIPR-Ab/GLP-1 peptide–antibody conjugate requires brain GIPR and GLP-1R for additive weight loss in obese mice - Nature

Click here to get full coverage on GIP Receptor Antagonism Eliminates Paradoxical Growth Hormone Secretion in Some Patients With Acromegaly - Endocrine Society

GIP Receptor Antagonism Eliminates Paradoxical Growth Hormone Secretion in Some Patients With Acromegaly  Endocrine Society

GIP Receptor Antagonism Eliminates Paradoxical Growth Hormone Secretion in Some Patients With Acromegaly - Endocrine Society

Click here to get full coverage on GIPR Sells Starbucks, Auburn University Properties to Clear $10.5M CMBS Debt in Strategic Move - Stock Titan

GIPR Sells Starbucks, Auburn University Properties to Clear $10.5M CMBS Debt in Strategic Move  Stock Titan

GIPR Sells Starbucks, Auburn University Properties to Clear $10.5M CMBS Debt in Strategic Move - Stock Titan

Click here to get full coverage on GIPR Announces Sale of Two Properties and Full Repayment of CMBS Loan - The Globe and Mail

GIPR Announces Sale of Two Properties and Full Repayment of CMBS Loan  The Globe and Mail

GIPR Announces Sale of Two Properties and Full Repayment of CMBS Loan - The Globe and Mail

Click here to get full coverage on Antag Therapeutics initiates Phase 1a trial of AT-7687, a - GlobeNewswire

Antag Therapeutics initiates Phase 1a trial of AT-7687, a  GlobeNewswire

Antag Therapeutics initiates Phase 1a trial of AT-7687, a - GlobeNewswire

Click here to get full coverage on Generation Income Properties Reports First Quarter Results, Operational Update, Initiates an Exploration of Strategic Alternatives - Yahoo Finance

Generation Income Properties Reports First Quarter Results, Operational Update, Initiates an Exploration of Strategic Alternatives  Yahoo Finance

Generation Income Properties Reports First Quarter Results, Operational Update, Initiates an Exploration of Strategic Alternatives - Yahoo Finance

Click here to get full coverage on How GIP Receptor Activation and Blockade Support Weight Loss - Technology Networks

How GIP Receptor Activation and Blockade Support Weight Loss  Technology Networks

How GIP Receptor Activation and Blockade Support Weight Loss - Technology Networks

Click here to get full coverage on GIP antagonism in focus as Versant doubles down on obesity with Antag bet - FirstWord Pharma

GIP antagonism in focus as Versant doubles down on obesity with Antag bet  FirstWord Pharma

GIP antagonism in focus as Versant doubles down on obesity with Antag bet - FirstWord Pharma

Click here to get full coverage on Novo Holdings-backed Antag raises $84M series A to send complementary obesity candidate to the clinic - Fierce Biotech

Novo Holdings-backed Antag raises $84M series A to send complementary obesity candidate to the clinic  Fierce Biotech

Novo Holdings-backed Antag raises $84M series A to send complementary obesity candidate to the clinic - Fierce Biotech

Click here to get full coverage on New Obesity Drugs Defy Logic – And Succeed - SciTechDaily

New Obesity Drugs Defy Logic – And Succeed  SciTechDaily

New Obesity Drugs Defy Logic – And Succeed - SciTechDaily

Click here to get full coverage on The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP - Frontiers

The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP  Frontiers

The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP - Frontiers

Click here to get full coverage on Unravelling the GIPR agonist versus antagonist paradox - Nature

Unravelling the GIPR agonist versus antagonist paradox  Nature

Unravelling the GIPR agonist versus antagonist paradox - Nature

Click here to get full coverage on Generation Income Properties Posts 33% Revenue Jump Despite $2.1M Q3 Loss - Stock Titan

Generation Income Properties Posts 33% Revenue Jump Despite $2.1M Q3 Loss  Stock Titan

Generation Income Properties Posts 33% Revenue Jump Despite $2.1M Q3 Loss - Stock Titan

Click here to get full coverage on Structural insights into the triple agonism at GLP-1R, GIPR and GCGR manifested by retatrutide | Cell Discovery - Nature

Structural insights into the triple agonism at GLP-1R, GIPR and GCGR manifested by retatrutide | Cell Discovery  Nature

Structural insights into the triple agonism at GLP-1R, GIPR and GCGR manifested by retatrutide | Cell Discovery - Nature

Click here to get full coverage on Resurgent Realty Trust Issues Open Letter to Generation Income Properties, Inc. (“GIPR”) - TradingView

Resurgent Realty Trust Issues Open Letter to Generation Income Properties, Inc. (“GIPR”)  TradingView

Resurgent Realty Trust Issues Open Letter to Generation Income Properties, Inc. (“GIPR”) - TradingView

Click here to get full coverage on Targeting a Fat Cell Receptor to Drive Weight Loss - the-scientist.com

Targeting a Fat Cell Receptor to Drive Weight Loss  the-scientist.com

Targeting a Fat Cell Receptor to Drive Weight Loss - the-scientist.com

Click here to get full coverage on RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program - TradingView

RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program  TradingView

RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program - TradingView

Click here to get full coverage on Pfizer develops new GIPR antagonists - BioWorld MedTech

Pfizer develops new GIPR antagonists  BioWorld MedTech

Pfizer develops new GIPR antagonists - BioWorld MedTech

Click here to get full coverage on The Daily REITBeat | Thursday, June 5th, 2025 (NASDAQ:GIPR) - Seeking Alpha

The Daily REITBeat | Thursday, June 5th, 2025 (NASDAQ:GIPR)  Seeking Alpha

The Daily REITBeat | Thursday, June 5th, 2025 (NASDAQ:GIPR) - Seeking Alpha

Click here to get full coverage on Pfizer's obesity ambitions suffer blow as danuglipron development scrapped - FirstWord Pharma

Pfizer's obesity ambitions suffer blow as danuglipron development scrapped  FirstWord Pharma

Pfizer's obesity ambitions suffer blow as danuglipron development scrapped - FirstWord Pharma

Click here to get full coverage on Mice with CNS KO of Gipr are resistant to diet-induced obesity a,... - researchgate.net

Mice with CNS KO of Gipr are resistant to diet-induced obesity a,...  researchgate.net

Mice with CNS KO of Gipr are resistant to diet-induced obesity a,... - researchgate.net

Click here to get full coverage on Resurgent Realty Trust Issues Open Letter to Fellow Generation Income Properties Shareholders - citybiz

Resurgent Realty Trust Issues Open Letter to Fellow Generation Income Properties Shareholders  citybiz

Resurgent Realty Trust Issues Open Letter to Fellow Generation Income Properties Shareholders - citybiz

Click here to get full coverage on AppLogic Networks Unveils 2025 Global Internet Phenomena Report: Key Insights into Internet Traffic Trends - Business Wire

AppLogic Networks Unveils 2025 Global Internet Phenomena Report: Key Insights into Internet Traffic Trends  Business Wire

AppLogic Networks Unveils 2025 Global Internet Phenomena Report: Key Insights into Internet Traffic Trends - Business Wire

Click here to get full coverage on Viking’s new dual GLP-1R/GIPR agonist expected to start Phase III trials soon - Clinical Trials Arena

Viking’s new dual GLP-1R/GIPR agonist expected to start Phase III trials soon  Clinical Trials Arena

Viking’s new dual GLP-1R/GIPR agonist expected to start Phase III trials soon - Clinical Trials Arena

Click here to get full coverage on Pfizer’s quest for market share in the ‘high stakes battleground’ of oral GLP-1s - Pharma Voice

Pfizer’s quest for market share in the ‘high stakes battleground’ of oral GLP-1s  Pharma Voice

Pfizer’s quest for market share in the ‘high stakes battleground’ of oral GLP-1s - Pharma Voice

Click here to get full coverage on Characterization of genetic variants of GIPR reveals a contribution of β-arrestin to metabolic phenotypes - Nature

Characterization of genetic variants of GIPR reveals a contribution of β-arrestin to metabolic phenotypes  Nature

Characterization of genetic variants of GIPR reveals a contribution of β-arrestin to metabolic phenotypes - Nature

Click here to get full coverage on Weight loss pursuant to treatment with the mGIPR-Ab/GLP-1... - researchgate.net

Weight loss pursuant to treatment with the mGIPR-Ab/GLP-1...  researchgate.net

Weight loss pursuant to treatment with the mGIPR-Ab/GLP-1... - researchgate.net

Click here to get full coverage on Distinct Identity of GLP-1R, GLP-2R, and GIPR Expressing Cells and Signaling Circuits Within the Gastrointestinal Tract - Frontiers

Distinct Identity of GLP-1R, GLP-2R, and GIPR Expressing Cells and Signaling Circuits Within the Gastrointestinal Tract  Frontiers

Distinct Identity of GLP-1R, GLP-2R, and GIPR Expressing Cells and Signaling Circuits Within the Gastrointestinal Tract - Frontiers

Click here to get full coverage on Helicore joins the Versant obesity stable with novel GIP antagonist - FirstWord Pharma

Helicore joins the Versant obesity stable with novel GIP antagonist  FirstWord Pharma

Helicore joins the Versant obesity stable with novel GIP antagonist - FirstWord Pharma

Click here to get full coverage on Fig. 2. Impact of homo-and heterodimerization in GLP-1R signaling. Arr3... - researchgate.net

Fig. 2. Impact of homo-and heterodimerization in GLP-1R signaling. Arr3...  researchgate.net

Fig. 2. Impact of homo-and heterodimerization in GLP-1R signaling. Arr3... - researchgate.net

Click here to get full coverage on Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism - Nature

Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism  Nature

Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism - Nature

Click here to get full coverage on Amino acid sequences of tirzepatide, NNC0090‐2746, glucagon‐like... - researchgate.net

Amino acid sequences of tirzepatide, NNC0090‐2746, glucagon‐like...  researchgate.net

Amino acid sequences of tirzepatide, NNC0090‐2746, glucagon‐like... - researchgate.net

Click here to get full coverage on The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets - Nature

The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets  Nature

The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets - Nature

Click here to get full coverage on (PDF) Glucose-dependent insulinotropic polypeptide and tissue inflammation: Implications for atherogenic cardiovascular disease - researchgate.net

(PDF) Glucose-dependent insulinotropic polypeptide and tissue inflammation: Implications for atherogenic cardiovascular disease  researchgate.net

(PDF) Glucose-dependent insulinotropic polypeptide and tissue inflammation: Implications for atherogenic cardiovascular disease - researchgate.net

Click here to get full coverage on Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor - ScienceDirect.com

Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor  ScienceDirect.com

Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor - ScienceDirect.com

Click here to get full coverage on The C-terminal regions of the GLP-1 and GIP receptors are not the key determinants of their differential arrestin recruitment but modulate the rate of receptor endocytosis - Frontiers

The C-terminal regions of the GLP-1 and GIP receptors are not the key determinants of their differential arrestin recruitment but modulate the rate of receptor endocytosis  Frontiers

The C-terminal regions of the GLP-1 and GIP receptors are not the key determinants of their differential arrestin recruitment but modulate the rate of receptor endocytosis - Frontiers

Click here to get full coverage on Role of GIP receptor in white adipose tissue (WAT). GIP receptor is... - researchgate.net

Role of GIP receptor in white adipose tissue (WAT). GIP receptor is...  researchgate.net

Role of GIP receptor in white adipose tissue (WAT). GIP receptor is... - researchgate.net

Click here to get full coverage on Molecular features of the ligand-free GLP-1R, GCGR and GIPR in complex with Gs proteins | Cell Discovery - Nature

Molecular features of the ligand-free GLP-1R, GCGR and GIPR in complex with Gs proteins | Cell Discovery  Nature

Molecular features of the ligand-free GLP-1R, GCGR and GIPR in complex with Gs proteins | Cell Discovery - Nature

Click here to get full coverage on Dual and triple agonists of GCG, GIP and GLP-1 receptors disclosed in Sun Pharmaceutical patent - BioWorld MedTech

Dual and triple agonists of GCG, GIP and GLP-1 receptors disclosed in Sun Pharmaceutical patent  BioWorld MedTech

Dual and triple agonists of GCG, GIP and GLP-1 receptors disclosed in Sun Pharmaceutical patent - BioWorld MedTech

Click here to get full coverage on A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings - Nature

A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings  Nature

A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings - Nature

Click here to get full coverage on Molecular dynamics-guided optimization of BGM0504 enhances dual-target agonism for combating diabetes and obesity - Nature

Molecular dynamics-guided optimization of BGM0504 enhances dual-target agonism for combating diabetes and obesity  Nature

Molecular dynamics-guided optimization of BGM0504 enhances dual-target agonism for combating diabetes and obesity - Nature

Click here to get full coverage on The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling - ScienceDirect.com

The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling  ScienceDirect.com

The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling - ScienceDirect.com

Click here to get full coverage on Antag Therapeutics: Developing Peptide-Based Treatments For Obesity Management - insights.citeline.com

Antag Therapeutics: Developing Peptide-Based Treatments For Obesity Management  insights.citeline.com

Antag Therapeutics: Developing Peptide-Based Treatments For Obesity Management - insights.citeline.com

Click here to get full coverage on Glucose-dependent insulinotropic polypeptide regulates body weight and food intake via GABAergic neurons in mice - Nature

Glucose-dependent insulinotropic polypeptide regulates body weight and food intake via GABAergic neurons in mice  Nature

Glucose-dependent insulinotropic polypeptide regulates body weight and food intake via GABAergic neurons in mice - Nature

Click here to get full coverage on Pfizer scraps experimental GLP-1 receptor after patient injury - Medical Marketing and Media

Pfizer scraps experimental GLP-1 receptor after patient injury  Medical Marketing and Media

Pfizer scraps experimental GLP-1 receptor after patient injury - Medical Marketing and Media

Click here to get full coverage on Phosphorylation Sites of the Gastric Inhibitory Polypeptide Receptor (GIPR) Revealed by Trapped-Ion-Mobility Spectrometry Coupled to Time-of-Flight Mass Spectrometry (TIMS-TOF MS) - ACS Publications

Phosphorylation Sites of the Gastric Inhibitory Polypeptide Receptor (GIPR) Revealed by Trapped-Ion-Mobility Spectrometry Coupled to Time-of-Flight Mass Spectrometry (TIMS-TOF MS)  ACS Publications

Phosphorylation Sites of the Gastric Inhibitory Polypeptide Receptor (GIPR) Revealed by Trapped-Ion-Mobility Spectrometry Coupled to Time-of-Flight Mass Spectrometry (TIMS-TOF MS) - ACS Publications

Click here to get full coverage on RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program - The Manila Times

RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program  The Manila Times

RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program - The Manila Times

Click here to get full coverage on Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors - Nature

Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors  Nature

Generation Income Properties Inc (GIPR)

Price Chart

Key Statistics

Technicals

About GIPR

Latest News

GIPR agonism and antagonism decrease body weight and food intake via different mechanisms in male mice - Nature

The role of GIPR in food intake control - Frontiers

The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice - ScienceDirect.com

Advanced Charts

Top Gainers

Top Losers